Back to Minerals

Does Selenium Prevent Cancer?

Does Selenium Prevent Cancer?
Supplements Guide 1 May 2026

Selenium and cancer prevention is one of the more instructive stories in nutrition research. A promising early finding generated enormous interest, a large trial was designed to confirm it, and the confirmation did not arrive.

Where did the hypothesis come from?

Observational studies had linked lower selenium status to higher cancer rates, and laboratory work suggested plausible mechanisms including antioxidant protection of DNA and effects on cell death pathways.

Geographical studies noted that regions with low soil selenium sometimes had higher cancer rates, though such comparisons are heavily confounded.

What did the early trial find?

A trial designed to test selenium for preventing skin cancer found no effect on skin cancer, and reported reductions in prostate, lung and colorectal cancer as secondary findings.

Those were secondary outcomes in a trial designed for something else, which is a well recognised source of spurious results. They were nonetheless striking enough to justify proper testing.

What did the large trial find?

The SELECT trial randomised over 35,000 men to selenium, vitamin E, both or placebo, specifically to test prostate cancer prevention.

It found no reduction in prostate cancer from selenium. It was stopped early, and follow up analysis found that vitamin E significantly increased prostate cancer risk.

There was also a non significant increase in type 2 diabetes in the selenium group, echoing a similar signal from the earlier trial.

Why did the results differ?

Several explanations have been proposed. Participants in the later trial had higher baseline selenium status, so there may have been no deficiency to correct.

The forms differed, with the earlier trial using selenium enriched yeast and the later one using selenomethionine. Doses and populations also differed.

The simplest explanation is that the original finding was a chance result from a secondary analysis, which is what replication is designed to detect.

What is the current position?

Reviews and cancer organisations do not recommend selenium supplements for cancer prevention. The evidence does not support it, and there are signals of possible harm.

Some research continues into whether benefit might exist specifically in people with low baseline selenium, which remains unresolved.

What about the diabetes signal?

This is the more concerning finding. Both major trials reported increases in type 2 diabetes among participants taking selenium, statistically significant in one and not the other.

The proposed mechanism involves selenoproteins interfering with insulin signalling. It is not proven and is consistent enough to counsel against routine supplementation in replete populations.

What lesson does this teach?

That a promising secondary finding is a hypothesis rather than a result, and that large trials designed to answer a specific question frequently overturn them.

The same pattern has appeared with beta carotene, vitamin E and several other antioxidants, often with harm rather than benefit emerging.

Should you take selenium?

Not for cancer prevention. Ensuring adequate intake through food is reasonable, and a couple of Brazil nuts a week or regular fish and eggs achieves it.

If you supplement, keep it modest at 50 to 100 micrograms and well below the upper limit of 300 to 400. This article is general information and not medical advice.

Does selenium status matter for cancer risk at all?

Observational studies continue to find associations between lower selenium status and some cancers, and observational data cannot separate selenium from everything that accompanies a better diet.

The randomised trials are the stronger evidence, and they did not confirm the observational picture, which is a recurring pattern in nutrition research.

Does the form or the population matter?

Possibly. Some researchers argue benefit may exist only in people with genuinely low baseline selenium, which most trial participants were not.

That hypothesis has not been properly tested, so it remains a plausible explanation rather than a reason to supplement.

Does this apply to other antioxidants?

The pattern is remarkably consistent. Beta carotene increased lung cancer in smokers, vitamin E increased prostate cancer, and several antioxidant combinations have failed.

Whole diets rich in these compounds look protective in observational studies while the isolated nutrients repeatedly fail in trials, which is one of the more important lessons in the field.